Holen Sie sich die Stockscreener-App
4.13
8.97%
0.34
Handel nachbörslich:
4.10
-0.03
-0.73%
Schlusskurs vom Vortag:
$3.79
Offen:
$3.77
24-Stunden-Volumen:
1.04M
Relative Volume:
0.59
Marktkapitalisierung:
$109.46M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-30.26M
KGV:
-2.0245
EPS:
-2.04
Netto-Cashflow:
$-24.69M
1W Leistung:
-9.23%
1M Leistung:
+69.96%
6M Leistung:
+40.48%
1J Leistung:
-25.72%
1-Tages-Spanne:
$3.70
$4.23
1-Wochen-Bereich:
$3.70
$4.6399
52-Wochen-Spanne:
$1.11
$5.60
Annovis Bio Inc Stock (ANVS) Company Profile
Firmenname
Annovis Bio Inc
Sektor
Branche
Telefon
484-875-3192
Adresse
101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA
Vergleichen Sie ANVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANVS
Annovis Bio Inc
|
4.13 | 100.45M | 0 | -30.26M | -24.69M | -2.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Annovis Bio Inc Stock (ANVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-10 | Herabstufung | D. Boral Capital | Buy → Hold |
| 2024-10-25 | Hochstufung | Maxim Group | Hold → Buy |
| 2023-12-29 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-07 | Bestätigt | Maxim Group | Buy |
Annovis Bio Inc Aktie (ANVS) Neueste Nachrichten
Keeping Neurodegeneration Top Of Mind: Is Annovis Bio's Pipeline Progress Enough? - RTTNews
Annovis Bio director Hoffman buys $193,794 in shares By Investing.com - Investing.com Canada
Annovis Bio (NYSE:ANVS) Director Purchases $193,950.00 in Stock - MarketBeat
Annovis Bio director Hoffman buys $193,794 in shares - Investing.com
Published on: 2025-12-08 04:36:17 - moha.gov.vn
Annovis Bio Inc. (ANVS) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Can Annovis Bio Inc. stock deliver consistent EPS growth2025 Retail Activity & High Yield Stock Recommendations - Newser
Is Annovis Bio Inc. stock a top hedge fund pickEarnings Beat & High Conviction Buy Zone Picks - Newser
Why institutional investors increase stakes in Annovis Bio Inc. stockEarnings Performance Report & Capital Efficiency Focused Ideas - Newser
Why Annovis Bio Inc. stock fits value portfoliosJuly 2025 Summary & Low Risk High Reward Ideas - Newser
Why Annovis Bio Inc. stock is a must watch tickerEarnings Risk Report & Weekly Watchlist for Consistent Profits - Newser
Annovis Bio (ANVS) Short Interest & Short Float | Updated Dec 2025 - MarketBeat
How Annovis Bio Inc. stock compares with top peers2025 Price Targets & Weekly Stock Breakout Alerts - Newser
How geopolitical risks impact Annovis Bio Inc. stockWeekly Trade Recap & Weekly Return Optimization Alerts - Newser
Annovis Bio (ANVS) Stock Analysis Report | Financials & Insights - Benzinga
Annovis Bio to Present Comprehensive Buntanetap Data at Parkinson Study Group Meeting - citybuzz
Annovis Bio, Inc. to Present At the 2025 Annual Meeting of the Parkinson Study Group - marketscreener.com
Annovis To Present at the 2025 Annual Meeting of the Parkinson Study Group - The Manila Times
Annovis Bio (NYSE: ANVS) to share buntanetap cognitive data in PD, AD at 2025 PSG meeting - Stock Titan
Annovis Rallies Around Phase 3 Alzheimer’s Push as New Data Signals Disease-Modifying Promise - MSN
Annovis Bio, Inc. (NYSE:ANVS) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Certain Stock Options of Annovis Bio, Inc. are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - marketscreener.com
Certain Warrants of Annovis Bio, Inc. are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - MarketScreener
Why analysts remain bullish on Annovis Bio Inc. stock2025 Earnings Impact & Daily Profit Focused Stock Screening - moha.gov.vn
Michael Hoffman Acquires 39,200 Shares of Annovis Bio (NYSE:ANVS) Stock - MarketBeat
Annovis Bio : Amendment to Statement of Changes in Beneficial Ownership (Form 4/A) - marketscreener.com
Annovis Bio director Hoffman buys $159k in shares By Investing.com - Investing.com Nigeria
Alzheimer's Disease Market to Evolve Rapidly Over the Next - openPR.com
Annovis Bio director Hoffman buys $159k in shares - Investing.com
Annovis Bio Director Michael B Hoffman Buys 39,200 Shares - TradingView
Director Makes Bold Move with Major Annovis Bio Stock Purchase - TipRanks
Parkinson’s Breakthrough? New Data Shows Drug May Reverse Cognitive Decline - MyChesCo
Annovis Announces Two Presentations at the CTAD 2025 Conference - The Manila Times
Annovis Bio director Hoffman buys $69.9k in ANVS stock By Investing.com - Investing.com Nigeria
Annovis Bio director Hoffman buys $69.9k in ANVS stock - Investing.com
Chmn Hoffman Buys 20,000 ($69.9K) Of Annovis Bio Inc [ANVS] - TradingView
Will Annovis Bio Inc. stock attract long term capital inflows2025 Short Interest & Intraday High Probability Setup Alerts - newser.com
How Annovis Bio Inc. stock reacts to stronger dollarJuly 2025 Technicals & Long-Term Safe Investment Ideas - newser.com
Annovis Bio Inc Stock Analysis and ForecastDividend Stability Analysis & Small Budget Capital Growth - earlytimes.in
How Annovis Bio Inc. stock reacts to monetary easingTake Profit & Verified Momentum Watchlists - newser.com
Can Annovis Bio Inc. stock deliver sustainable ROEWeekly Stock Report & Daily Volume Surge Trade Alerts - newser.com
Will Annovis Bio Inc. stock benefit from automationJuly 2025 Closing Moves & AI Forecasted Stock Moves - newser.com
Will Annovis Bio Inc. stock outperform Dow JonesShare Buyback & Detailed Earnings Play Alerts - newser.com
Finanzdaten der Annovis Bio Inc-Aktie (ANVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.08%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):